Skip to main content
Clinical Trials/ISRCTN28353453
ISRCTN28353453CompletedNot Applicable

A controlled trial of terlipressin plus banding ligation versus terlipressin alone in the management of acute esophageal variceal bleeding

Republic of China National Science Council (Taiwan)0 sites120 target enrollmentStarted: March 30, 2006Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
120

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. Cirrhotic patients
  • 2. Acute oesophageal variceal bleeding proven by emergency endoscopy within 12 hours

Exclusion Criteria

  • 1. Association with advanced hepatocellular carcinoma (HCC)
  • 2. Association with other severe systemic illness
  • 3. Association with gastric variceal bleeding
  • 4. Previous shunt operation, endoscopic variceal ligation (EVL), beta-blocker or isosorbide mononitrate (ISMN) within one month
  • 5. Serum bilirubin >10 mg/dl, creatinine >3 mg/dl
  • 6. Presence of encephalopathy >grade 2
  • 6. History of coronary artery disease
  • 7. Uncooperative

Investigators

Sponsor
Republic of China National Science Council (Taiwan)

Similar Trials